With a market capitalization of 4 billion dollars, Zealand Pharma, a Danish biotech founded in 1998 that also operates in the USA, is aiming to enter the highly lucrative anti-obesity drugs market. In... -January 24, 2024 at 10:14 am EST - MarketScreener